Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma

被引：0

作者：

Bhawana George

Suraj Konnath George

Wenyu Shi

Abedul Haque

Ping Shi

Ghazaleh Eskandari

Magnus Axelson

Olle Larsson

Ahmed O. Kaseb

Hesham M. Amin

机构：

[1] The University of Texas MD Anderson Cancer Center,Department of Hematopathology

[2] Affiliated Hospital of the University of Nantong,Department of Hematology

[3] East China University of Science and Technology,State Key Laboratory of Bioreactor Engineering

[4] Karolinska Institute,Department of Molecular Medicine and Surgery

[5] Karolinska Institute,Department of Oncology and Pathology

[6] The University of Texas MD Anderson Cancer Center,Depertment of Gastrointestinal Medical Oncology

[7] MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences,undefined

来源：

Journal of Hematology & Oncology | / 16卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
George, Bhawana
George, Suraj Konnath
Shi, Wenyu
Haque, Abedul
Shi, Ping
Eskandari, Ghazaleh
Axelson, Magnus
Larsson, Olle
Kaseb, Ahmed O.
Amin, Hesham M.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[2] Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma
Bhawana George
Suraj Konnath George
Wenyu Shi
Abedul Haque
Ping Shi
Ghazaleh Eskandari
Magnus Axelson
Olle Larsson
Ahmed O. Kaseb
Hesham M. Amin
Journal of Hematology & Oncology, 12
[3] Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphoma (vol 12, 80, 2019)
George, Bhawana
George, Suraj Konnath
Shi, Wenyu
Haque, Abedul
Shi, Ping
Eskandari, Ghazaleh
Axelson, Magnus
Larsson, Olle
Kaseb, Ahmed O.
Amin, Hesham M.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
[4] The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK+ T-cell lymphoma
Deeksha Vishwamitra
Choladda V Curry
Serhan Alkan
Yao-Hua Song
Gary E Gallick
Ahmed O Kaseb
Ping Shi
Hesham M Amin
Molecular Cancer, 14
[5] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
Shi, Ping
Lai, Raymond
Lin, Quan
Iqbal, Abid S.
Young, Leah C.
Kwak, Larry W.
Ford, Richard J.
Amin, Hesham M.
BLOOD, 2009, 114 (02) : 360 - 370
[6] Detection of NPM-ALK-reactive T-cell responses with long overlapping peptides in NPM-ALK+ anaplastic large cell lymphoma (ALCL) patients
Singh, V. K.
Werner, S.
Damm-Welk, C.
Lennerz, V.
Woelfel, T.
Woessmann, W.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 73 - 73
[7] The ALK inhibitor ASP3026 eradicates NPM-ALK+ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model
George, Suraj Konnath
Vishwamitra, Deeksha
Manshouri, Roxsan
Shi, Ping
Amin, Hesham M.
ONCOTARGET, 2014, 5 (14) : 5750 - 5763
[8] Functional synergism between IGF-IR tyrosine kinase and NPM-ALK oncogene identifies a novel role of IGF-IR in malignant lymphoma
Shi, Ping
Lin, Quan
Iqbal, Abid S.
Kwak, Larry W.
Lai, Raymond
Amin, Hesham M.
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3555S - 3555S
[9] PGDFR blockade as a novel therapy for NPM-ALK+ anaplastic large cell lymphoma
Kenner, Lukas
Kuroll, Madeleine
Hartmann, Tanja
Krenn, Peter
Schlederer, Michaela
Prutsch, Nicole
Greil, Richard
Turner, Suzanne
Merkel, Olaf
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 : 28 - 28
[10] Analysis of nucleophosmin-anaplastic lymphoma kinase (NPM-ALK)-reactive CD8+ T cell responses in children with NPM-ALK+ anaplastic large cell lymphoma
Singh, V. K.
Werner, S.
Hackstein, H.
Lennerz, V.
Reiter, A.
Woelfel, T.
Damm-Welk, C.
Woessmann, W.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 186 (01): : 96 - 105

← 1 2 3 4 5 →